The goal of all clinical trials is to be as inclusive as possible. However, it is necessary to develop specific inclusion and exclusion criteria. The reason for this is to...
Read More
San Francisco, CA (June 25, 2024)—CONQUEST, a highly innovative platform clinical trial conceived of and led by the Scleroderma Research Foundation (SRF) and designed to rapidly advance promising treatments for...
Read More
We are honored to announce that CONQUER has enrolled its 1,000th participant! 🎉 In 2018, the SRF launched the CONQUER Registry (an acronym for COllaborative National QUality and Efficacy Registry)—a first-of-its-kind nationwide…
SRF funded-investigator Dr. Howard Chang of the Stanford University School of Medicine is working on an innovative project to understand disease-relevant mechanisms in scleroderma: his novel Twin Study is investigating differences in genetically identical twins where one twin has scleroderma and...
Read More
SAN FRANCISCO (May 9, 2022) – The Scleroderma Research Foundation (SRF) will host its inaugural Virtual Patient Forum, Collaborating for a Cure, on Wednesday, June 1, 2022, to kick off...
Read More
Meet Sarah Wood, the Clinical/Translational Research Coordinator at Vanderbilt University Medical Center. A recently graduated master's student who researched autoimmune diseases, she's now turning her focus to ending scleroderma. She...
Read More
In 2018, the SRF launched CONQUER (COllaborative, National Quality and Efficacy Registry), a first-of-its-kind nationwide, longitudinal registry of scleroderma patients. For those who live with scleroderma, participating in CONQUER is...
Read More
As we say hello to March, we're sharing this month's edition of eNews. Highlights include: ➡️ Two of Bob Saget’s friends, John Mayer and Candace Cameron Bure, honor his dedication...
Read More
Research is the best hope for finding a cure. This is why in 2018, the SRF launched CONQUER (COllaborative, National QUality and Efficacy Registry), a first-of-its-kind nationwide, longitudinal registry of...
Read More
The SRF launched the CONQUER Registry in 2018 through a collaborative effort with the largest scleroderma centers in the U.S. The goal of this registry is the enrollment of thousands...
Read More
